Condition

Chronic Inflammatory Demyelinating Polyneuropathy clinical trials and research

• 11Clinical trials
• 4NIH research projects
• 51Countries

Newest Chronic Inflammatory Demyelinating Polyneuropathy clinical trials

All recruiting trials (11)

• KITE-363 treatment for relapsed or refractory autoimmune neurologic diseases

  This study will test whether KITE-363 is safe and can help people with relapsed or treatment-resistant autoimmune neurologic diseases such as MS, CIDP, and myasthenia gravis.

  Recruiting at 10 sites Phase 1 Gilead Sciences · Newport Beach, California and 9 other locations · NCT07304154

• Immunoadsorption treatment for chronic inflammatory demyelinating polyneuropathy

  This observational study will try immunoadsorption as a next-step treatment for adults with CIDP who do not respond well to IVIg or methylprednisolone.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07154524

• Empasiprubart for adults with CIDP

  This study will test whether IV empasiprubart helps improve symptoms and is safe for adults with CIDP, with an initial 24-week randomized comparison to placebo followed by two years of empasiprubart for all participants.

  Recruiting at 94 sites Phase 3 argenx · Birmingham, Alabama and 93 other locations · NCT07091630

• Imeroprubart for adults with CIDP

  This study will test whether the monoclonal antibody Imeroprubart helps adults with active CIDP who are already on stable immunoglobulin or corticosteroid treatment.

  Recruiting at 117 sites Phase 2 Immunovant Sciences GmbH · Tucson, Arizona and 141 other locations · NCT07032662

• Empasiprubart versus IVIg for treating CIDP in adults

  This trial tests whether empasiprubart works as well as IVIg and is safe for adults with CIDP who currently benefit from IVIg.

  Recruiting at 107 sites Phase 3 argenx · Birmingham, Alabama and 106 other locations · NCT06920004

• Evaluating DNTH103 for treating chronic inflammatory demyelinating polyneuropathy

  This study is testing a new treatment called DNTH103 to see if it can help adults with chronic inflammatory demyelinating polyneuropathy feel better and stay safe.

  Recruiting at 201 sites Phase 3 Dianthus Therapeutics · Birmingham, Alabama and 200 other locations · NCT06858579

• KIg10 (intravenous human immune globulin 10%) maintenance therapy for CIDP

  This trial will test whether two different maintenance doses of IV immune globulin (KIg10), given every three weeks, help adults with CIDP stay stable and avoid worsening.

  Recruiting at 6 sites Phase 3 Kedrion S.p.A. · Stamford, Connecticut and 5 other locations · NCT06752356

• Testing riliprubart for treating chronic inflammatory demyelinating polyneuropathy

  This study is testing if a new treatment called riliprubart can work better than the usual IVIg treatment for adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

  Recruiting at 129 sites Phase 3 Sanofi · Homewood, Alabama and 133 other locations · NCT06290141

• Predicting decline in CIDP patients during IVIg treatment adaptation

  This study is trying to see if we can predict when people with CIDP might get worse during their IVIg treatment by monitoring their health and daily movements over a year.

  Recruiting Centre Hospitalier Universitaire de Liege · Liège, Liège · NCT06183645

• Comparing IVIG and SCIG dosing for CIDP

  This trial will test whether body composition changes how IVIG and SCIG deliver protective antibodies in adults with CIDP.

  Recruiting Phase 1 Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT05584631

• Using Hizentra® for treating Chronic Inflammatory Demyelinating Polyneuropathy

  This study is testing how well Hizentra® works for people with Chronic Inflammatory Demyelinating Polyneuropathy when switching from an IV treatment to a shot under the skin.

  Recruiting at 24 sites CSL Behring · Amiens and 26 other locations · NCT04672733

NIH-funded research (4)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• B-cell problems in chronic inflammatory demyelinating polyneuropathy (CIDP)

  Researchers are looking at how B cells and the antibodies they make may damage nerves in people with CIDP to help guide better treatments.

  NIH research Yale University · New Haven, United States · NIH-11308721

• Small skin sample to help detect and track CIDP

  This project tests whether a tiny skin biopsy can help doctors find and follow CIDP in people who have or may have the condition.

  NIH research Yale University · New Haven, United States · NIH-11295151

• Aging, T cells, and CIDP: how senescence may drive nerveautoimmunity

  This grant looks at why CIDP, a chronic autoimmune nerve disease, happens more in older people by studying aging-like changes in immune cells and how they might push nerve cells to become dysfunctional.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11294895

• Understanding B-cell dysfunction in chronic inflammatory demyelinating polyneuropathy

  This study is looking into how certain immune cells called B-cells might be causing problems in people with chronic inflammatory demyelinating polyneuropathy (CIDP), with the goal of finding better treatments for this condition.

  NIH research Yale University · New Haven, United States · NIH-11063185

Related topics

Quick answers

How many Chronic Inflammatory Demyelinating Polyneuropathy clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 51 countries. The most sites are in United States (8 trials), Germany (5 trials), Argentina (5 trials), Brazil (5 trials), France (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →